PURE Bioscience, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period
PURE Bioscience, Inc. (PURE) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period of 131.25 thousand shares for the 12-month period ending 2019-07-31, per its 10-K filed 2019-10-30.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod · last filed 2019-10-30
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2019 was 131.25K shares, a 85.17% decline from fiscal 2018.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2018 was 885.00K shares.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2015 was 500.00K shares, a 150.00% increase from fiscal 2014.
- PURE Bioscience, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeited in period for fiscal 2014 was 200.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period 12 month |
|---|---|
| 2019-07-31 | 131.25K shares 10-K · filed 2019-10-30 |
| 2018-07-31 | 885.00K shares 10-K · filed 2019-10-30 |
| 2015-07-31 | 500.00K shares 10-K · filed 2015-10-28 |
| 2014-07-31 | 200.00K shares 10-K · filed 2015-10-28 |